We are live on ! Find out more
ELV icon

Elevance Health

1,109 hedge funds and large institutions have $59.5B invested in Elevance Health in 2020 Q2 according to their latest regulatory filings, with 138 funds opening new positions, 395 increasing their positions, 391 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 76

29% more capital inflows, than outflows

Capital inflows: $3.94B | Capital outflows: $3.04B

5% more funds holding

Funds holding: 1,054 → 1,109 (+55)

1.08% more ownership

Funds ownership: 88.79% → 89.87% (+1.1%)

1% more repeat investments, than reductions

Existing positions increased: 395 | Existing positions reduced: 391

11% less call options, than puts

Call options by funds: $648M | Put options by funds: $730M

20% less funds holding in top 10

Funds holding in top 10: 35 → 28 (-7)

Holders
1,109
Holders Change
+55
Holders Change %
+5.22%
% of All Funds
22.67%
Holding in Top 10
28
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-20%
% of All Funds
0.57%
New
138
Increased
395
Reduced
391
Closed
76
Calls
$648​M
Puts
$730​M
Net Calls
-⁠$81.9​M
Net Calls Change
-⁠$58.9​M

ELV Hedge Fund Activity: Q2 2020 in Review

1,109 of the 4,891 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q2 2020, worth a combined $59.5B — up 17% from $50.8B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new ELV positions and 76 closed out — a net gain of 62 holders — while 395 added to existing stakes and 391 trimmed.

The largest buyer was Nordea Investment Management, adding an estimated $588M. The largest seller was Viking Global Investors, exiting entirely with an estimated $411M sold.

  • 1,109 institutional investors held Elevance Health (ELV) as of Q2 2020, up from 1,054 in Q1 2020.
  • Funds reported $59.5B of Elevance Health stock for Q2 2020, up 17% quarter-over-quarter.
  • 138 funds opened new Elevance Health positions in Q2 2020 and 76 closed out, a net change of +62 holders.
  • The largest Elevance Health buyer in Q2 2020 was Nordea Investment Management, an estimated $588M added.
  • The largest Elevance Health seller in Q2 2020 was Viking Global Investors, an estimated $411M sold.

Based on aggregated 13F filings for Q2 2020.